BioCentury | Feb 7, 2019
Finance

Pharma ventures earlier

...eight companies, including three preclinical neuroscience companies -- Magnolia Neurosciences Corp., Yumanity Therapeutics LLC and System1 Biosciences Inc....
...develop a yeast-based screening platform to identify targets related to protein misfolding for neurodegenerative diseases. System1 Biosciences Inc....
...Obsidian Therapeutics Inc., Cambridge, Mass. Pfizer Inc. (NYSE:PFE), New York, N.Y. Ribometrix Inc., Durham, N.C. System1 Biosciences Inc....
BioCentury | Sep 14, 2018
Financial News

Neurological organoid company System1 raises $25M in series A

...George Zachary and Pfizer Venture's Margi McLoughlin joined System1's board. System1 Biosciences Inc., San Francisco, Calif. Elizabeth S. Eaton System1 Biosciences Inc....
BioCentury | Oct 4, 2010
Company News

Acea Biosciences, Cellular Dynamics, Roche deal

The companies combined CDI's iCell Cardiomyocytes with ACEA's and Roche's xCELLigence RTCA System to develop a tool to evaluate the potential cardiotoxic effects of new and previously marketed cardiac compounds. The tool is in beta...
BioCentury | Sep 29, 2008
Clinical News

Bordetella pertussin and parapertussin molecular test regulatory update

Health Canada granted marketing approval for EraGen's in vitro molecular diagnostic test for Bordetella pertussis and parapertussis. The test is to be performed on the company's MultiCode-RTx real-time PCR system. EraGen Biosciences Inc. , Madison, Wis....
BioCentury | Sep 29, 2008
Clinical News

Cytomegalovirus regulatory update

Health Canada granted marketing approval for EraGen's in vitro molecular diagnostic test for cytomegalovirus (CMV). The test is to be performed on the company's MultiCode-RTx real-time PCR system. EraGen Biosciences Inc. , Madison, Wis. Product: Cytomegalovirus...
BioCentury | Sep 29, 2008
Clinical News

Enterovirus molecular test regulatory update

Health Canada granted marketing approval for EraGen's in vitro molecular diagnostic test for enterovirus. The test is to be performed on the company's MultiCode-RTx real-time PCR system. EraGen Biosciences Inc. , Madison, Wis. Product: Enterovirus molecular...
BioCentury | Sep 29, 2008
Clinical News

Herpes simplex virus regulatory update

Health Canada granted marketing approval for EraGen's in vitro molecular diagnostic test for herpes simplex virus (HSV) 1 and 2. The test is to be performed on the company's MultiCode-RTx real-time PCR system. EraGen Biosciences...
BioCentury | Sep 29, 2008
Clinical News

Influenza types A and B molecular test regulatory update

Health Canada granted marketing approval for EraGen's in vitro molecular diagnostic test for influenza virus A and B. The test is to be performed on the company's MultiCode-RTx real-time PCR system. EraGen Biosciences Inc. , Madison,...
BioCentury | Feb 5, 2007
Clinical News

Tissue Repair Cells regulatory update

FDA granted Orphan Drug designation to ASTM's Tissue repair cells to treat dilated cardiomyopathy (DCM). The TRCs are derived from bone marrow containing adult stem cells using the company's AastromReplicell system. Aastrom Biosciences Inc. (ASTM),...
BioCentury | Mar 27, 2006
Clinical News

Tissue Repair Cells regulatory update

FDA granted Orphan Drug designation to Tissue Repair Cells to treat osteonecrosis. The TRCs are made from bone marrow containing adult stem cells using the AastromReplicell System. Aastrom Biosciences Inc. (ASTM), Ann Arbor, Mich. Product:...
Items per page:
1 - 10 of 20
BioCentury | Feb 7, 2019
Finance

Pharma ventures earlier

...eight companies, including three preclinical neuroscience companies -- Magnolia Neurosciences Corp., Yumanity Therapeutics LLC and System1 Biosciences Inc....
...develop a yeast-based screening platform to identify targets related to protein misfolding for neurodegenerative diseases. System1 Biosciences Inc....
...Obsidian Therapeutics Inc., Cambridge, Mass. Pfizer Inc. (NYSE:PFE), New York, N.Y. Ribometrix Inc., Durham, N.C. System1 Biosciences Inc....
BioCentury | Sep 14, 2018
Financial News

Neurological organoid company System1 raises $25M in series A

...George Zachary and Pfizer Venture's Margi McLoughlin joined System1's board. System1 Biosciences Inc., San Francisco, Calif. Elizabeth S. Eaton System1 Biosciences Inc....
BioCentury | Oct 4, 2010
Company News

Acea Biosciences, Cellular Dynamics, Roche deal

The companies combined CDI's iCell Cardiomyocytes with ACEA's and Roche's xCELLigence RTCA System to develop a tool to evaluate the potential cardiotoxic effects of new and previously marketed cardiac compounds. The tool is in beta...
BioCentury | Sep 29, 2008
Clinical News

Bordetella pertussin and parapertussin molecular test regulatory update

Health Canada granted marketing approval for EraGen's in vitro molecular diagnostic test for Bordetella pertussis and parapertussis. The test is to be performed on the company's MultiCode-RTx real-time PCR system. EraGen Biosciences Inc. , Madison, Wis....
BioCentury | Sep 29, 2008
Clinical News

Cytomegalovirus regulatory update

Health Canada granted marketing approval for EraGen's in vitro molecular diagnostic test for cytomegalovirus (CMV). The test is to be performed on the company's MultiCode-RTx real-time PCR system. EraGen Biosciences Inc. , Madison, Wis. Product: Cytomegalovirus...
BioCentury | Sep 29, 2008
Clinical News

Enterovirus molecular test regulatory update

Health Canada granted marketing approval for EraGen's in vitro molecular diagnostic test for enterovirus. The test is to be performed on the company's MultiCode-RTx real-time PCR system. EraGen Biosciences Inc. , Madison, Wis. Product: Enterovirus molecular...
BioCentury | Sep 29, 2008
Clinical News

Herpes simplex virus regulatory update

Health Canada granted marketing approval for EraGen's in vitro molecular diagnostic test for herpes simplex virus (HSV) 1 and 2. The test is to be performed on the company's MultiCode-RTx real-time PCR system. EraGen Biosciences...
BioCentury | Sep 29, 2008
Clinical News

Influenza types A and B molecular test regulatory update

Health Canada granted marketing approval for EraGen's in vitro molecular diagnostic test for influenza virus A and B. The test is to be performed on the company's MultiCode-RTx real-time PCR system. EraGen Biosciences Inc. , Madison,...
BioCentury | Feb 5, 2007
Clinical News

Tissue Repair Cells regulatory update

FDA granted Orphan Drug designation to ASTM's Tissue repair cells to treat dilated cardiomyopathy (DCM). The TRCs are derived from bone marrow containing adult stem cells using the company's AastromReplicell system. Aastrom Biosciences Inc. (ASTM),...
BioCentury | Mar 27, 2006
Clinical News

Tissue Repair Cells regulatory update

FDA granted Orphan Drug designation to Tissue Repair Cells to treat osteonecrosis. The TRCs are made from bone marrow containing adult stem cells using the AastromReplicell System. Aastrom Biosciences Inc. (ASTM), Ann Arbor, Mich. Product:...
Items per page:
1 - 10 of 20